Octreotide Acetate Injection, Solution
Product Images NDC 68083-516

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 68083-516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Octreotide-spl-1000-mcg-carton (Octreotide Spl 1000 Mcg Carton)

FDA Label Image

Octreotide-spl-1000-mcg-vial (Octreotide Spl 1000 Mcg Vial)

Octreotide-spl-1000-mcg-vial (Octreotide Spl 1000 Mcg Vial)
This is a description of a medication called Octreotide Acetate Injection. It is available in a 5 mL Multiple-Dose Vial for subcutaneous or intravenous injection. Each mL of the solution contains 200 meg of octreotide (as acetate). The medication should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F) and protected from light. After opening the vial, it should be discarded within 14 days. The medication is manufactured by Gland Pharma Limited in Hyderabad, India. The lot number and expiration date are not available.*
FDA Label Image

Octreotide-spl-5000-mcg-carton (Octreotide Spl 5000 Mcg Carton)

FDA Label Image

Octreotide-spl-5000-mcg-vial (Octreotide Spl 5000 Mcg Vial)

Octreotide-spl-5000-mcg-vial (Octreotide Spl 5000 Mcg Vial)
This text provides information about a medication called "Octreotide Acetate Injection". It is intended for subcutaneous or intravenous injection. The medication is stored in a 5 mL multiple-dose vial and each mL of the solution contains 1000 meg of octreotide (as acetate). It needs to be refrigerated at a temperature between 2°C to 8°C (36°F to 46°F) and protected from light. After initial use, it should be discarded within 14 days. The medication is manufactured by Gland Pharma Limited in Hyderabad, India. The lot number and expiration date are not readable.*
FDA Label Image

Octreotide-spl-structure (Octreotide Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.